Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

9.15B

Market cap9.15B

Price-Earnings ratio

-3.13

Price-Earnings ratio-3.13

Dividend yield

—

Dividend yield—

Average volume

12.82M

Average volume12.82M

High today

$25.42

High today$25.42

Low today

$23.18

Low today$23.18

Open price

$25.19

Open price$25.19

Volume

31.29M

Volume31.29M

52 Week high

$75.37

52 Week high$75.37

52 Week low

$23.15

52 Week low$23.15

MRNA News

TipRanks 20h

Moderna says research has demonstrated safety profile of Spikevax

Moderna (MRNA) issued the following statement on the safety of Spikevax: “The safety of Spikevax is rigorously monitored by Moderna, the U.S. FDA, and regulator...

Analyst ratings

59%

of 27 ratings

Buy

22.2%

Hold

59.3%

Sell

18.5%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.